MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-19-2026
Guardant Health P/S Ratio 2011-2026 | GH
Annual P/S Ratio Guardant Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.7 | 7.91 | 4.44 | 5.92 | 27.1 | 43.8 | 33.4 | 13.4 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 43.8 | 4.44 | 18.7 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M |  USA |
 |
Agilent Technologies
A
|
6.64 | $ 118.69 | -0.89 % | $ 36.1 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
6.87 | $ 21.75 | 5.79 % | $ 234 M |  China |
 |
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
2.61 | $ 22.48 | 27.95 % | $ 1.2 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Exact Sciences Corporation
EXAS
|
6 | - | - | $ 19.8 B | USA |
 |
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
9.4 | $ 1.44 | 1.41 % | $ 1.92 M | USA |
 |
Castle Biosciences
CSTL
|
2.14 | $ 24.46 | -0.65 % | $ 679 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
1.92 | $ 180.08 | -0.32 % | $ 8.93 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | USA |
 |
Danaher Corporation
DHR
|
6.09 | $ 194.49 | -1.82 % | $ 139 B | USA |
 |
Interpace Biosciences
IDXG
|
0.19 | $ 2.2 | - | $ 9.73 M | USA |
 |
Medpace Holdings
MEDP
|
5.12 | $ 524.38 | 1.13 % | $ 15.1 B | USA |
 |
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
3.75 | $ 132.01 | -0.19 % | $ 21 B | USA |
 |
NeoGenomics
NEO
|
2.04 | $ 8.19 | -5.65 % | $ 1.05 B | USA |
 |
Neogen Corporation
NEOG
|
1.14 | $ 9.27 | -1.59 % | $ 2.01 B | USA |
 |
Fulgent Genetics
FLGT
|
1.65 | $ 16.18 | 0.06 % | $ 489 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.8 | $ 28.77 | -1.03 % | $ 20 B |  Niderland |
 |
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B | Niderland |
 |
Anixa Biosciences
ANIX
|
0.718 | $ 2.82 | -3.75 % | $ 91.5 K | USA |
 |
Biomerica
BMRA
|
1.35 | $ 2.18 | 3.32 % | $ 5.01 M | USA |
 |
ICON Public Limited Company
ICLR
|
3.25 | $ 117.75 | 1.07 % | $ 9.71 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
1.71 | $ 267.87 | 0.36 % | $ 22.3 B | USA |
 |
Senseonics Holdings
SENS
|
9.94 | $ 6.8 | -1.45 % | $ 284 M | USA |
 |
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K |  Israel |
 |
Soleno Therapeutics
SLNO
|
10.9 | $ 52.59 | 0.03 % | $ 2.67 B | USA |
 |
Myriad Genetics
MYGN
|
0.496 | $ 5.11 | -1.64 % | $ 473 M | USA |
 |
Lantheus Holdings
LNTH
|
3.32 | $ 82.82 | -1.34 % | $ 5.59 B | USA |
 |
Neuronetics
STIM
|
0.544 | $ 1.4 | 0.42 % | $ 92.3 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.11 | $ 192.41 | 0.56 % | $ 21.4 B | USA |
 |
ENDRA Life Sciences
NDRA
|
1.59 K | $ 5.17 | 0.58 % | $ 4.07 M | USA |
 |
Thermo Fisher Scientific
TMO
|
4.4 | $ 519.51 | -2.26 % | $ 196 B | USA |
 |
Trinity Biotech plc
TRIB
|
1.47 | $ 0.69 | -1.42 % | $ 61.9 M | Irlanda |
 |
Invitae Corporation
NVTA
|
4.18 | - | - | $ 21.2 M | USA |